Crossmark

A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancer

Crossref DOI link: https://doi.org/10.1007/s00261-021-03334-y

Published Online: 2021-10-31

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fergadi, Maria P.

Magouliotis, Dimitrios E.

Rountas, Christos

Vlychou, Marianna

Athanasiou, Thanos

Symeonidis, Dimitris

Pappa, Polyxeni A.

Zacharoulis, Dimitris http://orcid.org/0000-0002-8972-064X
License Information

Text and Data Mining valid from 2021-10-31

Version of Record valid from 2021-10-31
More Information

Article History

Received: 30 July 2021

Revised: 20 October 2021

Accepted: 22 October 2021

First Online: 31 October 2021

Declarations

:

: The authors have no conflicts of interest to declare that are relevant to the content of this article.

: Does not apply.

: Does not apply.

: Does not apply.

: Does not apply.

Document is current

Any future updates will be listed below